Leading Independent Investment Research, Morningstar, Inc.

Morningstar

Leading Independent Investment Research

Morningstar, Inc.

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. We offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors. 

Morningstar provides data on more than 500,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 16 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries, with more than $180 billion in assets under advisement or management as of June 30, 2015. We have operations in 27 countries.

Download the Morningstar Fact Sheet : http://corporate.morningstar.com/US/documents/MarketingFactSheets/AboutMorningstarFactsheet.pdf

Equity Bottom-Up

Dr. Reddy's Laboratories / Equity Bottom-Up

<ul><li class="p1">Dr. Reddy's low-cost manufacturing and emerging-market exposure add up to attractive growth prospects.</li><li class="p1">The company has a well-established brand in many emerging markets where rising disposable income, a fragmented customer base, and lower generic drug utilization rates offer attractive growth opportunities.</li></ul><p><em>Analysts: Michael Waterhouse &amp; Kelsey Tsai</em></p>

Dr. Reddy's low-cost manufacturing and emerging-market exposure add up to attractive growth prospects.The company has a well-established brand in many emerging markets where rising disposable income, a fragmented customer base, and lower generic drug utilization rates offer attractive growth opportunities.Analysts: Michael Waterhouse &amp; Kelsey Tsai

U.S. Market Share Gains and a Large Emerging-Market Presence Should Uphold Dr. Reddy's Growth.